Abstract
The present research work was aimed to design the transdermal delivery system of naproxen using Aloe vera as aqueous gel base. Aloe vera would able to potentiate the anti-inflammatory effect and also act as penetration enhancer. Carbopol 934 was used as a gelling agent. The prepared gel was assessed for pH, permeation parameters, drug content, skin irritation and in-vitro diffusion. Accelerated stability study was also carried out. In-vivo studies were performed to characterize the efficacy of the prepared naproxen-Aloe vera transgel (NAG). The pH of formulation was found to be 6.98. The values of permeation data for flux, permeability coefficient and enhancement ratio were obtained as 0.00907 µg cm-2 h-1, 0.00453 cm h-1 and 5.96 respectively. The viscosity was found as 610 cps for NAG. The drug release kinetics followed Higuchi model. Stability study has proved the integrity of the formulation. No skin irritation was observed in Wistar albino rats. Anti-inflammatory assessment in Wistar rats showed significant effect in paw-volume reduction at p<0.05 in less than one hour for NAG compared to that of plain Aloe gel and commercial naproxen gel (CNG). The prepared naproxen-Aloe gel (NAG) could able to show better anti-inflammatory activity compared to the CNG. This could be attributed by synergistic effect of Aloe.
Keywords: Diffusion, flux, paw edema, percent inhibition, permeability enhancement.
Drug Delivery Letters
Title:Pharmaceutical and Pharmacodynamic Evaluation of Naproxen Incorporated Aloe vera Transgel
Volume: 4 Issue: 2
Author(s): Thushara B. Dudala, Prasanna R. Yalavarthi, Rao P. Satyanarayana, Haritha Kodavatikanti, K.R. Vandana, Vinesha Velam and Harini C. Vadlamudi
Affiliation:
Keywords: Diffusion, flux, paw edema, percent inhibition, permeability enhancement.
Abstract: The present research work was aimed to design the transdermal delivery system of naproxen using Aloe vera as aqueous gel base. Aloe vera would able to potentiate the anti-inflammatory effect and also act as penetration enhancer. Carbopol 934 was used as a gelling agent. The prepared gel was assessed for pH, permeation parameters, drug content, skin irritation and in-vitro diffusion. Accelerated stability study was also carried out. In-vivo studies were performed to characterize the efficacy of the prepared naproxen-Aloe vera transgel (NAG). The pH of formulation was found to be 6.98. The values of permeation data for flux, permeability coefficient and enhancement ratio were obtained as 0.00907 µg cm-2 h-1, 0.00453 cm h-1 and 5.96 respectively. The viscosity was found as 610 cps for NAG. The drug release kinetics followed Higuchi model. Stability study has proved the integrity of the formulation. No skin irritation was observed in Wistar albino rats. Anti-inflammatory assessment in Wistar rats showed significant effect in paw-volume reduction at p<0.05 in less than one hour for NAG compared to that of plain Aloe gel and commercial naproxen gel (CNG). The prepared naproxen-Aloe gel (NAG) could able to show better anti-inflammatory activity compared to the CNG. This could be attributed by synergistic effect of Aloe.
Export Options
About this article
Cite this article as:
B. Dudala Thushara, R. Yalavarthi Prasanna, P. Satyanarayana Rao, Kodavatikanti Haritha, Vandana K.R., Velam Vinesha and C. Vadlamudi Harini, Pharmaceutical and Pharmacodynamic Evaluation of Naproxen Incorporated Aloe vera Transgel, Drug Delivery Letters 2014; 4 (2) . https://dx.doi.org/10.2174/22103031113039990012
DOI https://dx.doi.org/10.2174/22103031113039990012 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Color-Coded Fluorescent Protein Imaging of Angiogenesis: The AngioMouse® Models
Current Pharmaceutical Design Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
Current Cancer Drug Targets Animal Models for Growth Hormone Gene Therapy
Current Gene Therapy Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives
Current Biotechnology Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV
Current Pharmaceutical Design Recent Progress on Tumor Missile Therapy and Tumor Vascular Targeting Therapy as a New Approach
Current Vascular Pharmacology Hydatid Disease: Current Status of Chemotherapy and Drug Delivery Systems
Current Drug Therapy Investigations of Malignant Mesothelioma
Current Respiratory Medicine Reviews Stem Cell Regenerative Potential Combined with Nanotechnology and Tissue Engineering for Myocardial Regeneration
Current Stem Cell Research & Therapy Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome
Current Genomics Anticancer Lignans - from Discovery to Biotechnology
Mini-Reviews in Medicinal Chemistry Advances in Synthesis and Medicinal Applications of Compounds Derived from Phthalimide
Current Organic Synthesis Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design The Novel VEGF<sub>121</sub>-VEGF<sub>165</sub> Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF<sub>165</sub>/Lon Signaling Through PI3K-AKT-mTOR Pathway
Current Cancer Drug Targets Bypassing Cancer Resistance by Antagonizing “Inhibitor of Apoptosis Proteins” (IAPs)
Current Signal Transduction Therapy